Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.78 is 100% above its 5-year average of -302593.36, near the high end of its 5-year range (-1698639.00–-0.78).
As of the fiscal period ended Wednesday, December 31, 2025. 90.59% above its 12-month average of -8.29.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.21.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 16 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.78
EARNINGS PER SHARE (EPS) AVG TTM
-8.29
EARNINGS PER SHARE (EPS) AVG 3Y
-9461.74
EARNINGS PER SHARE (EPS) AVG 5Y
-302593.36
EARNINGS PER SHARE (EPS) AVG 10Y
-182288.47
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+90.59%
CURRENT VS 3Y AVG
+99.99%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Allarity Therapeutics, Inc.
Market Cap
$15.91M
Earnings Per Share (EPS)
-0.78
TTM Avg
-8.29
3Y Avg
-9461.74
5Y Avg
-302593.36
Market Cap
$16.22M
Earnings Per Share (EPS)
-0.76
TTM Avg
-2.06
3Y Avg
-5.59
5Y Avg
-9.29
Market Cap
$15.30M
Earnings Per Share (EPS)
-0.77
TTM Avg
-1.25
3Y Avg
-1.82
5Y Avg
-1.86
Market Cap
$16.54M
Earnings Per Share (EPS)
-0.21
TTM Avg
-0.22
3Y Avg
-0.25
5Y Avg
-0.30
Market Cap
$16.58M
Earnings Per Share (EPS)
-3.73
TTM Avg
-46.49
3Y Avg
-194.14
5Y Avg
-195.03
Market Cap
$14.28M
Earnings Per Share (EPS)
-2.11
TTM Avg
-3.38
3Y Avg
-4.90
5Y Avg
-6.31
Market Cap
$13.55M
Earnings Per Share (EPS)
-29.90
TTM Avg
-175.25
3Y Avg
-40254.86
5Y Avg
-180507.78
Market Cap
$13.34M
Earnings Per Share (EPS)
-4.56
TTM Avg
-22.43
3Y Avg
-71.26
5Y Avg
-107.32
Market Cap
$18.77M
Earnings Per Share (EPS)
-0.25
TTM Avg
-0.29
3Y Avg
-0.28
5Y Avg
-0.20
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | $15.91M | -0.78 | -8.29 | -9461.74 | -302593.36 |
| BioCardia, Inc. (BCDA)vs › | $16.22M | -0.76 | -2.06 | -5.59 | -9.29 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | -0.77 | -1.25 | -1.82 | -1.86 |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | -0.21 | -0.22 | -0.25 | -0.30 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | -3.73 | -46.49 | -194.14 | -195.03 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.28M | -2.11 | -3.38 | -4.90 | -6.31 |
| Vyome Holdings, Inc. (HIND)vs › | $13.55M | -29.90 | -175.25 | -40254.86 | -180507.78 |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.34M | -4.56 | -22.43 | -71.26 | -107.32 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | -0.25 | -0.29 | -0.28 | -0.20 |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -0.66 | -0.90 | -9.28 | -9.88 |
Trailing EPS (TTM)
$-0.78
Forward EPS (Est.)
$-0.80
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.78 |
| 2024-12-31 | -15.79 |
| 2023-12-31 | -6031.31 |
| 2022-12-31 | -31799.09 |
| 2021-12-31 | -79074.18 |
| 2020-12-31 | -1698639.00 |
| 2019-12-31 | -189613.00 |
| 2018-12-31 | 0.00 |
| 2017-12-31 | 0.00 |
| 2016-12-31 | 0.00 |
| 2015-12-31 | 0.00 |
| 2014-12-31 | -0.06 |
| 2013-12-31 | 0.00 |
